Zobrazeno 1 - 10
of 262
pro vyhledávání: '"Felix Hilpert"'
Autor:
Dhanya Ramachandran, Jonathan P. Tyrer, Stefan Kommoss, Anna DeFazio, Marjorie J. Riggan, AOCS Group, Penelope M. Webb, Peter A. Fasching, Diether Lambrechts, María J. García, Cristina Rodríguez-Antona, Marc T. Goodman, Francesmary Modugno, Kirsten B. Moysich, Beth Y. Karlan, Jenny Lester, Susanne K. Kjaer, Allan Jensen, Estrid Høgdall, Ellen L. Goode, William A. Cliby, Amanika Kumar, Chen Wang, Julie M. Cunningham, Stacey J. Winham, Alvaro N. Monteiro, Joellen M. Schildkraut, Daniel W. Cramer, Kathryn L. Terry, Linda Titus, Line Bjorge, Liv Cecilie Vestrheim Thomsen, OPAL Study Group, Tanja Pejovic, Claus K. Høgdall, Iain A. McNeish, Taymaa May, David G. Huntsman, Jacobus Pfisterer, Ulrich Canzler, Tjoung-Won Park-Simon, Willibald Schröder, Antje Belau, Lars Hanker, Philipp Harter, Jalid Sehouli, Rainer Kimmig, Nikolaus de Gregorio, Barbara Schmalfeldt, Klaus Baumann, Felix Hilpert, Alexander Burges, Boris Winterhoff, Peter Schürmann, Lisa-Marie Speith, Peter Hillemanns, Andrew Berchuck, Sharon E. Johnatty, Susan J. Ramus, Georgia Chenevix-Trench, Paul D. P. Pharoah, Thilo Dörk, Florian Heitz
Publikováno v:
npj Genomic Medicine, Vol 9, Iss 1, Pp 1-12 (2024)
Abstract Survival from ovarian cancer depends on the resection status after primary surgery. We performed genome-wide association analyses for resection status of 7705 ovarian cancer patients, including 4954 with high-grade serous carcinoma (HGSOC),
Externí odkaz:
https://doaj.org/article/ac0253f401c44385bb41f701da028a0c
Autor:
Philipp Harter, Jan Hauke, Florian Heitz, Alexander Reuss, Stefan Kommoss, Frederik Marmé, André Heimbach, Katharina Prieske, Lisa Richters, Alexander Burges, Guido Neidhardt, Nikolaus de Gregorio, Ahmed El-Balat, Felix Hilpert, Werner Meier, Rainer Kimmig, Karin Kast, Jalid Sehouli, Klaus Baumann, Christian Jackisch, Tjoung-Won Park-Simon, Lars Hanker, Sandra Kröber, Jacobus Pfisterer, Heidrun Gevensleben, Andreas Schnelzer, Dimo Dietrich, Tanja Neunhöffer, Mathias Krockenberger, Sara Y Brucker, Peter Nürnberg, Holger Thiele, Janine Altmüller, Josefin Lamla, Gabriele Elser, Andreas du Bois, Eric Hahnen, Rita Schmutzler
Publikováno v:
PLoS ONE, Vol 12, Iss 10, p e0186043 (2017)
Identification of families at risk for ovarian cancer offers the opportunity to consider prophylactic surgery thus reducing ovarian cancer mortality. So far, identification of potentially affected families in Germany was solely performed via family h
Externí odkaz:
https://doaj.org/article/939baee6a8de4d379fefaf2e08e2274a
Autor:
Pauline Wimberger, Mara Julia Gerber, Jacobus Pfisterer, Kati Erdmann, Susanne Füssel, Theresa Link, Andreas du Bois, Stefan Kommoss, Florian Heitz, Jalid Sehouli, Rainer Kimmig, Nikolaus de Gregorio, Barbara Schmalfeldt, Tjoung-Won Park-Simon, Klaus Baumann, Felix Hilpert, Marcel Grube, Willibald Schröder, Alexander Burges, Antje Belau, Lars Hanker, Jan Dominik Kuhlmann
Publikováno v:
Clinical Cancer Research. 28:4660-4668
Purpose: The identification of a robust IHC marker to predict the response to antiangiogenic bevacizumab in ovarian cancer is of high clinical interest. VEGF-A, the molecular target of bevacizumab, is expressed as multiple isoforms with pro- or antia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::438bd6c6abfa0f0cfbe5ed74603115e7
https://doi.org/10.1158/1078-0432.ccr-22-1326
https://doi.org/10.1158/1078-0432.ccr-22-1326
Autor:
Rachel Campbell, Daniel S.J. Costa, Martin R. Stockler, Yeh Chen Lee, Jonathan A. Ledermann, Dominique Berton, Jalid Sehouli, Felicia T. Roncolato, Rachel O. Connell, Aikou Okamoto, Jane Bryce, Amit M. Oza, Elisabeth Avall-Lundqvist, Jonathan S. Berek, Anne Lanceley, Florence Joly, Felix Hilpert, Amanda Feeney, Marie C. Kaminsky, Katrina Diamante, Michael L. Friedlander, Madeleine T. King
Publikováno v:
Gynecologic Oncology. 166:254-262
The Measure of Ovarian Symptoms and Treatment (MOST) concerns is a validated patient-reported symptom assessment tool for assessing symptom benefit and adverse effects of palliative chemotherapy in women with recurrent ovarian cancer (ROC). We aimed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5807414259d2fdbf932232575215d830
https://doi.org/10.1016/j.ygyno.2022.05.024
https://doi.org/10.1016/j.ygyno.2022.05.024
Autor:
Kylie L. Gorringe, Ian G. Campbell, Kaylene J. Simpson, Richard B. Pearson, David G. Huntsman, David D.L. Bowtell, Susan J. Ramus, Felix Hilpert, Andreas du Bois, Jacobus Pfisterer, Stefan Kommoss, Anna Wu, Malcolm C. Pike, Celeste Leigh Pearce, Jacek Gronwald, Jan Lubinski, Aleksandra Gentry-Maharaj, Usha Menon, Maria P. Intermaggio, Sian Fereday, Nadia Traficante, Joshy George, Michael S. Anglesio, Karen E. Sheppard, Sally J. Davis
MetaCore analysis results
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26f650e4c7d4802f3d3168ef36084b94
https://doi.org/10.1158/1535-7163.22501114
https://doi.org/10.1158/1535-7163.22501114
Autor:
Kylie L. Gorringe, Ian G. Campbell, Kaylene J. Simpson, Richard B. Pearson, David G. Huntsman, David D.L. Bowtell, Susan J. Ramus, Felix Hilpert, Andreas du Bois, Jacobus Pfisterer, Stefan Kommoss, Anna Wu, Malcolm C. Pike, Celeste Leigh Pearce, Jacek Gronwald, Jan Lubinski, Aleksandra Gentry-Maharaj, Usha Menon, Maria P. Intermaggio, Sian Fereday, Nadia Traficante, Joshy George, Michael S. Anglesio, Karen E. Sheppard, Sally J. Davis
Identification of genomic alterations defining ovarian carcinoma subtypes may aid the stratification of patients to receive targeted therapies. We characterized high-grade serous ovarian carcinoma (HGSC) for the association of amplified and overexpre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f5876dd86cd7bd57d9f342ef0b7a208
https://doi.org/10.1158/1535-7163.c.6536680.v1
https://doi.org/10.1158/1535-7163.c.6536680.v1
Autor:
Kylie L. Gorringe, Ian G. Campbell, Kaylene J. Simpson, Richard B. Pearson, David G. Huntsman, David D.L. Bowtell, Susan J. Ramus, Felix Hilpert, Andreas du Bois, Jacobus Pfisterer, Stefan Kommoss, Anna Wu, Malcolm C. Pike, Celeste Leigh Pearce, Jacek Gronwald, Jan Lubinski, Aleksandra Gentry-Maharaj, Usha Menon, Maria P. Intermaggio, Sian Fereday, Nadia Traficante, Joshy George, Michael S. Anglesio, Karen E. Sheppard, Sally J. Davis
Nanostring data including clinical information
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33850242d88e61d3fb9460d6a6cb54a6
https://doi.org/10.1158/1535-7163.22501117.v1
https://doi.org/10.1158/1535-7163.22501117.v1
Autor:
Kylie L. Gorringe, Ian G. Campbell, Kaylene J. Simpson, Richard B. Pearson, David G. Huntsman, David D.L. Bowtell, Susan J. Ramus, Felix Hilpert, Andreas du Bois, Jacobus Pfisterer, Stefan Kommoss, Anna Wu, Malcolm C. Pike, Celeste Leigh Pearce, Jacek Gronwald, Jan Lubinski, Aleksandra Gentry-Maharaj, Usha Menon, Maria P. Intermaggio, Sian Fereday, Nadia Traficante, Joshy George, Michael S. Anglesio, Karen E. Sheppard, Sally J. Davis
Supplementary Figures S1 (Nanostring data and combined PFS for BMP8B and ATP13A4), S2 (Nanostring expression histograms), S3 (GAB2 survival by cohort), S4 (BMP8B and ATP13A4 survival by cohort), S5 (Metacore network maps); Supplementary Tables S2 (Ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ac913a275640646ceea4dbf6642bd0e
https://doi.org/10.1158/1535-7163.22501120.v1
https://doi.org/10.1158/1535-7163.22501120.v1
Autor:
Jan Dominik Kuhlmann, Lars Hanker, Antje Belau, Alexander Burges, Willibald Schröder, Marcel Grube, Felix Hilpert, Klaus Baumann, Tjoung-Won Park-Simon, Barbara Schmalfeldt, Nikolaus de Gregorio, Rainer Kimmig, Jalid Sehouli, Florian Heitz, Stefan Kommoss, Andreas du Bois, Theresa Link, Susanne Füssel, Kati Erdmann, Jacobus Pfisterer, Mara Julia Gerber, Pauline Wimberger
Purpose:The identification of a robust IHC marker to predict the response to antiangiogenic bevacizumab in ovarian cancer is of high clinical interest. VEGF-A, the molecular target of bevacizumab, is expressed as multiple isoforms with pro- or antian
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67c902d0457c9b3e6f80a5c74e2c85cf
https://doi.org/10.1158/1078-0432.c.6532776
https://doi.org/10.1158/1078-0432.c.6532776
Autor:
Jan Dominik Kuhlmann, Lars Hanker, Antje Belau, Alexander Burges, Willibald Schröder, Marcel Grube, Felix Hilpert, Klaus Baumann, Tjoung-Won Park-Simon, Barbara Schmalfeldt, Nikolaus de Gregorio, Rainer Kimmig, Jalid Sehouli, Florian Heitz, Stefan Kommoss, Andreas du Bois, Theresa Link, Susanne Füssel, Kati Erdmann, Jacobus Pfisterer, Mara Julia Gerber, Pauline Wimberger
Supplementary Figure from Bevacizumab May Differentially Improve Prognosis of Advanced Ovarian Cancer Patients with Low Expression of VEGF-A165b, an Antiangiogenic VEGF-A Splice Variant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::229c884a530284a906ad424da5896063
https://doi.org/10.1158/1078-0432.22488633
https://doi.org/10.1158/1078-0432.22488633